Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

2024-9-1

Research in Brief

2024-9-1

Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases

2024-9-1

Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study

2024-9-1

Uveitis relapse in Behçet's disease: a more nuanced approach is needed

2024-9-1

Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study

2024-9-1

Advancing research and equity through collaboration

2024-8-19

Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

2024-8-1

Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort

2024-8-1

Navigating the complexities of pregnancy in rheumatic disease

2024-8-1

Correction to Lancet Rheumatol 2024; 6: e537–45

2024-8-1

Pregnancy outcome predictors in systemic lupus erythematosus: prospective for brighter perspectives

2024-8-1

Research in Brief

2024-8-1

Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism

2024-8-1

Reclassifying ANCA-associated vasculitis: a focus on kidney disease

2024-8-1

Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis

2024-8-1

The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study

2024-8-1

Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab

2024-8-1

Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people

2024-8-1

Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study

2024-8-1

A future for prediction and treatment of Sjögren's disease-associated lymphomas

2024-8-1

Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

2024-8-1

Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis

2024-8-1

The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management

2024-8-1

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

2024-8-1

Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

2024-7-9

Arthritis complicating inflammatory bowel disease— the future is now

2024-7-1

Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study

2024-7-1

Contesting the BACPAP consortium's consensus – Authors' reply

2024-7-1

Fighting to be heard—a painful journey of misdiagnoses

2024-7-1

Towards improving the Global Burden of Disease estimates for low back pain

2024-7-1

Correction to Lancet Rheumatol 2023; 5: e130–38

2024-7-1

Advancing predictive accuracy for shoulder replacement surgery

2024-7-1

Gout prevalence is rising in low-income and middle-income countries: are we ready?

2024-7-1

Calcium pyrophosphate deposition disease

2024-7-1

Contesting the BACPAP consortium's consensus

2024-7-1

Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis

2024-7-1

Risk of serious adverse events after primary shoulder replacement: development and external validation of a prediction model using linked national data from England and Denmark

2024-7-1

Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care

2024-7-1

Pneumococcal vaccine in adults with immune-mediated inflammatory diseases

2024-7-1

Biosimilars in childhood chronic rheumatic diseases: friend or foe?

2024-7-1

Systemic lupus erythematosus: managing cardiovascular risk factors

2024-7-1

Digital self-management for back pain in the UK

2024-7-1

Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework

2024-7-1

Painful scalp nodules in SAPHO syndrome

2024-7-1

Stop ticking boxes: it just doesn't work

2024-7-1

Research in Brief

2024-6-17

Research, pregnancy, and the ethics of parental consent

2024-6-13

Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

2024-6-13

Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

2024-6-13